If you further did research into how long calcium influx continues into heart muscles post stroke causing continual damage and why this drug will work in humans just like preclinical studies because the science already proves it in human hearts which is lined all over with TRPC 3,6,7 channels:
“Calcium influx into heart muscle cells following a stroke can have varying durations depending on the specific muscle tissue and the severity of the stroke. In some cases, calcium influx can be observed for several hours post-stroke and may persist for days or weeks”
AGN will put brain protection in the bag for NYR. Drug more than ever is lining up to become a billion dollar plus company and a takeover target in the next 1-2 years. This 20 milllion market cap is not where this should be trading at especially it’s showing so far it’s safe in humans
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)